Reuters -- Pfizer Inc (PFE.N), the world’s largest drugmaker, and Osaka-based Takeda Pharmaceutical Co Ltd 4502.T8 said on Tuesday they have signed an agreement to jointly promote and sell Takeda’s diabetes drug in China.